The FDA's decisions in July will ripple across that market as well
rda Pickart L, Vasquez-Soltero JM, Margolina A
Chapman LE, Darling AL, Brown JE
Issue: No measurable vision improvement after 3 months Potential causes: Unrealistic expectations (expecting improvement vs slowed decline), advanced disease with minimal salvageable tissue, inadequate dosing or inconsistent use, wrong peptide for specific condition, peptides genuinely ineffective for individual, progression monitoring inadequate missing subtle benefits
Clear, colorless solution indicates good quality
Key Technical Specifications: Peptide Fragment: Modified amino acid sequence Molecular Formula: C78H123N23O23S2 Purity: 99% (HPLC verified) Format: Lyophilized powder Storage: Stable at room temperature for short-term handling